Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study.
Robert
Nicholas
N
US OncologyVirginia Cancer Specialists, 8503 Arlington Blvd, #400, Fairfax, VA, USA. Nicholas.Robert@usoncology.com
Krekow
Lea
L
Stokoe
Chris
C
Clawson
Alicia
A
Iglesias
Jose
J
O'Shaughnessy
Joyce
J